Bryan Wahl

Bryan Wahl is a declared insider of Tarsus Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 29 November 2022 and 17 March 2026, the trades on record add up to 11 filings.

The open-market record consists of 5 sales worth €415k, with no purchase. Outside the open market, there are 6 option exercises. 2026 to date brings no purchases and 1 sale.

Most recently, on 19 March 2026, the filings show an open-market sale worth €247k in Tarsus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.